Pharma IQ Members

Stuart Carroll &
Alasdair Williams

Stuart Carroll & Alasdair Williams

Stuart Carroll is a Senior Health Economist specialising in pharmaceuticals and health policy.  He studied a BA (Hons) in Politics and Economics (1stClass) at the University of Northumbria at Newcastleand an MSc in Health Economics (Distinction) from the University of York.  Stuart currently heads up the health economics, health outcomes and epidemiology functions in the UK for a leading pharmaceutical company specialising in vaccines, and is studying for an MBA at Imperial College.  He has authorship credits in a number of policy papers on topics including military healthcare, the National Institute for Health and Clinical Excellence(NICE), the Quality and Outcomes Framework (QOF), health education, value-based pricing (VBP), public health and obesity, the role of pharmacy, and hospice care.  In 2008, Stuart researched and wrote the Conservative Party’s official policy on NICE, ‘Improving Access to New Drugs: A Plan to Renew the National Institute for Health and Clinical Excellence’.  Stuart is also a Policy Fellow for Health & Education at the centre right think tank, the Bow Group, a guest blogger for 2020health, and a Fellow at the Royal Society of Public Health.  

Alasdair Williams is Head of Grapevine at Creston Health, a specialist local marketing-communications agency for the healthcare industry.  Alasdair joined Grapevine from Sanofi Pasteur MSD where he worked for 13 years in a variety of sales, marketing and commercial roles. Most recently as Associate Director he managed the UK vaccine tender business, supply chain and strategic planning for the company.  Before that he was Marketing Manager for the pre-launch and launch of cervical cancer vaccine Gardasil. Alasdair graduated from Newcastle University, with a BSc (Hons) in Physiological Sciences and holds an advanced diploma for pharmaceutical professionals from Cambridge University.

116 results
of 12
Simpler, faster, less expensive – yet compliant: how the Internet of Things (IoT) shakes up the management of cold chain medicines...Full Article »
Tags:
In this presentation from TetraScience, focus will be on actionable steps to getting started with digital transformation in the lab and seeing results....Full Article »
Tags:
Join this session of the SmartLab Global Academy to hear insight from Jan Hauss, Head of R&D LIMS IT Manager and Merck KGaA on the subject of airtight IT security in the lab...Full Article »
Tags:
Different lab informatics applications (and their acronyms) have multiplied exponentially in the past decade. This webinar discusses the opportunity for technologies to converge together – creating more integrated lab informatics solutions which further streamline workflows and increase efficiencies....Full Article »
Tags:
This webinar panel will advocate that User Experience (UX) design offers unlocked benefits to the R&D life science industry....Full Article »
Tags:
In this session, Esko’s Mike Baird reviews best practices gleaned from years of successful deployments in global pharmaceutical companies so you can avoid the pitfalls and reap the benefits....Full Article »
Tags:
This session will discuss gains in efficiency and data quality that are to be found in drug discovery by capturing data generated by support workflows....Full Article »
Tags:
This presentation will review key informatics trends for the lab and discuss practical steps toward delivering transformational business value that can drive operational efficiency and transform data into insights....Full Article »
Tags:
Attendees will learn about a fully-integrated, temperature monitoring solution which provides automated data download, alerting and reporting, enabling greater access to data while reducing the man hours needed to manage the supply chain....Full Article »
Tags:
Join our data experts from Veeva and Ernst and Young to hear analysis on key findings from recent European survey on customer data and explore customer data best practices to support your digital transformation and better respond to compliance constraints....Full Article »
Tags:
116 results
of 12